BioStacks

Herb

Ginger

Evidence

Strong

Reviewed May 2026

Evidence: 4 of 5 (Strong)

11 studies cited · 2 meta-analyses · 4 systematic reviews

What the evidence says

Ginger is traditionally used for digestive comfort and nausea relief. Generally well tolerated. No established RDA/UL.

Multiple clinical trials and traditional use for digestive comfort and nausea relief

Top Ginger supplements for…

Supports

General HealthStrong
Bone & JointModerate

Top Ginger supplements

4/5

Strong

11

RCTs reviewed

0

Null results

Strong evidence for nausea — pregnancy, chemotherapy, post-operative, motion sickness. Real but modest signal for knee osteoarthritis pain and menstrual cramps. Glycemic claims are weaker and oversold.

On a blood thinner or scheduled for surgery? Stop ginger 2 weeks before any procedure — antiplatelet effects stack with NSAIDs and anticoagulants. Active gallstones is a contraindication.

Research dossier

Clinical research on Ginger

11 trials reviewed across 3 indications.

Strongest evidence

Nausea — pregnancy, chemotherapy, post-operative, motion sickness

Strong

Mechanism

Gingerols and shogaols antagonize 5-HT3 and substance P receptors in the gut and brainstem chemoreceptor trigger zone, dampen gastric inflammation, and accelerate gastric emptying. The pharmacology overlaps with prescription antiemetics — that's why it actually works.

Across four nausea contexts, the evidence converges. The Borrelli 2005 systematic review (n=675) and Vutyavanich and Smith RCTs establish 1 g/day for pregnancy nausea — ACOG-recognized non-pharmacological option. Ryan 2012 (n=576) shows ginger augments 5-HT3 antiemetics in chemotherapy. Chaiyakunapruk 2006 confirms post-operative benefit. Mowrey 1982 anchors motion sickness. Few supplements have this much converging evidence.

Adjunct in chemotherapy and post-operative settings, not a replacement for prescription antiemetics. In pregnancy, the standard recommendation is to discuss with an OB before regular use, even though low doses are widely considered safe.

Trials cited

  • Borrelli systematic review — ginger for pregnancy nausea

    positive · Systematic review

    Borrelli, Capasso, Aviello, Pittler & Izzo, 2005, Obstetrics & Gynecologyn=675

    Pooled 6 double-blind RCTs (n=675) plus a 187-patient observational cohort. Ginger consistently outperformed placebo on nausea severity and vomiting frequency, and was non-inferior to vitamin B6 in head-to-head data. Established the evidence base behind ACOG's recognition of ginger as a non-pharmacological NVP option.

    Heterogeneous formulations and dosing across trials. Most studies were short (≤3 weeks) — long-term safety data in pregnancy is limited.

  • Vutyavanich — ginger 1g/day for pregnancy nausea

    positive · RCT

    Vutyavanich, Kraisarin & Ruangsri, 2001, Obstetrics & Gynecologyn=70

    Double-masked RCT of 70 women with NVP. 1 g/day ginger over 4 days significantly reduced both nausea VAS scores and vomiting episodes versus placebo (p<0.001), with 87.5% of ginger users reporting symptom improvement vs 28.1% on placebo. Clean small trial that anchored the 1 g/day dose used in subsequent research.

    Small sample, short duration. No follow-up safety data on longer-duration gestational use.

  • Smith — ginger vs vitamin B6 for pregnancy nausea

    positive · RCT

    Smith, Crowther, Willson, Hotham & McMillian, 2004, Obstetrics & Gynecologyn=291

    Equivalence trial in 291 early-pregnancy women. 1.05 g/day ginger matched 75 mg/day pyridoxine on nausea, retching, and vomiting reduction over 3 weeks. Establishes ginger as a clinically equivalent alternative to a standard pharmacological NVP option.

    Equivalence to B6 is the relevant statistic, not superiority over placebo. No placebo arm in this trial.

  • Ryan — ginger for chemotherapy-induced nausea (URCC CCOP)

    positive · RCT

    Ryan et al., 2012, Supportive Care in Cancern=576

    Multicenter trial in 576 chemotherapy patients across 23 community oncology sites. Ginger extract added to standard antiemetics significantly reduced acute nausea on chemotherapy day 1. The 0.5 g and 1.0 g doses gave the largest reductions; 1.5 g did not improve further. Adjunct, not standalone — ginger augmented 5-HT3 antiemetics, did not replace them.

    Effect was on acute (day-1) nausea, not delayed nausea. Trial used a standardized ginger extract, not raw root or tea.

  • Marx review — ginger mechanisms in chemotherapy-induced nausea

    positive · Systematic review

    Marx, Ried, McCarthy, Vitetta, Sali, McKavanagh & Isenring, 2017, Critical Reviews in Food Science and Nutrition

    Systematic review of ginger for chemotherapy-induced nausea and vomiting. Synthesized RCTs alongside the proposed mechanism — 5-HT3 antagonism, substance P antagonism, anti-inflammatory action, and gastric prokinetic effects. Conclusion: ginger is a plausible adjunct to standard antiemetics, with the strongest evidence for acute (rather than delayed) nausea.

    Heterogeneous trial quality and varying ginger formulations make pooled effect estimates imprecise.

  • Mowrey & Clayson — ginger vs dimenhydrinate for motion sickness

    positive · RCT

    Mowrey & Clayson, 1982, Lancetn=36

    Crossover RCT in 36 highly motion-sensitive adults. 940 mg ginger outperformed 100 mg dimenhydrinate at preventing GI symptoms during a rotating-chair challenge — half the ginger group survived the full 6-minute test versus none in the dimenhydrinate group. Old, small, but the study that put ginger on the motion-sickness map.

    Small sample, single acute challenge, no replication at the same magnitude. Modern motion-sickness reviews position ginger as an option, not a first-line treatment.

  • Ernst & Pittler — systematic review of ginger for nausea

    mixed · Systematic review

    Ernst & Pittler, 2000, British Journal of Anaesthesia

    Pooled 6 RCTs of ginger across nausea contexts. Individual studies in seasickness, morning sickness, and chemotherapy nausea favored ginger. The pooled post-operative analysis (1 g pre-operatively) was non-significant — driven by methodological heterogeneity more than null mechanism. The split mirrors what the field has confirmed since: ginger works, post-op evidence specifically is uneven.

    Older review; superseded for post-op specifically by Chaiyakunapruk 2006, which found a positive pooled effect with stricter inclusion.

  • Chaiyakunapruk meta-analysis — ginger for post-operative nausea

    positive · Meta-analysis

    Chaiyakunapruk, Kitikannakorn, Nathisuwan, Leeprakobboon & Leelasettagool, 2006, American Journal of Obstetrics and Gynecologyn=363

    Pooled 5 RCTs (n=363) of pre-operative ginger ≥1 g for post-operative nausea. Significant reductions in both nausea (RR 0.69) and vomiting (RR 0.61) versus placebo. Updates the earlier Ernst & Pittler null and supports ginger as a non-pharmacological PONV adjunct.

    Effect strongest at ≥1 g pre-operatively. Small sample sizes within each pooled trial; relative-risk estimates have wide confidence intervals.

Knee osteoarthritis pain

Mechanism

Gingerols inhibit COX-2 and 5-LOX inflammatory enzymes and dampen NF-κB signaling — a mechanism overlap with NSAIDs without the same GI cost. Dose-response in joint trials supports a real anti-inflammatory effect at therapeutic doses.

Bartels 2015 meta-analysis of 5 RCTs (n=593) shows pain SMD −0.30 and disability SMD −0.22 versus placebo at 500–1,000 mg/day standardized extract. NNT for clinically meaningful pain improvement is around 9. Real, modest effect — useful as an NSAID-sparing adjunct, not a stand-alone solution for moderate-severe disease.

Tested mostly in knee OA. No long-term cartilage-protection data. Effect is modest, not curative.

  • Altman & Marcussen — ginger extract for knee osteoarthritis

    positive · RCT

    Altman & Marcussen, 2001, Arthritis & Rheumatismn=247

    Double-blind RCT in 247 knee OA patients. Standardized ginger extract significantly outperformed placebo on knee pain on standing — 63% responders vs 50% (p=0.048). Modest absolute effect: a 13-percentage-point gap is real but not transformative.

    The extract combined Zingiber officinale and Alpinia galanga — generalization to single-herb ginger products is imperfect. Effect size is modest.

  • Bartels meta-analysis — ginger for osteoarthritis

    positive · Meta-analysis

    Bartels et al., 2015, Osteoarthritis and Cartilagen=593

    Pooled 5 RCTs (n=593) of ginger for osteoarthritis. Statistically significant pain reduction (SMD −0.30) and disability reduction (SMD −0.22) versus placebo. NNT for ≥30% pain improvement is roughly 9 — modest, not a replacement for NSAIDs in moderate-severe disease.

    Authors graded evidence quality as moderate. Most pooled trials were small with mixed methodology. Real signal, not a knee-OA cure.

Menstrual cramps (primary dysmenorrhea)

Mechanism

Same COX-2 inhibition that drives the joint signal — relevant for prostaglandin-mediated menstrual cramps.

Pooled 7 RCTs of 750–2,000 mg/day ginger powder during the first 3–4 days of menstruation. Significant pain reduction versus placebo, with head-to-head data showing comparable effect to mefenamic acid (NSAID). The cleanest non-NSAID option for menstrual cramps.

Dose during the first days of bleeding — not as a baseline supplement. Preventive daily dosing was not the trial design.

  • Daily systematic review — ginger for primary dysmenorrhea

    positive · Systematic review

    Daily, Zhang, Kim & Park, 2015, Pain Medicine

    Pooled 7 RCTs of ginger for primary dysmenorrhea. 750–2,000 mg/day during the first days of menstruation significantly reduced pain VAS scores versus placebo, with effect sizes comparable to mefenamic acid in head-to-head trials. The cleanest non-NSAID option for menstrual cramps.

    Small individual trials with varied ginger preparations. Effect requires dosing during the first days of bleeding — preventive baseline dosing is not what was tested.

5 forms of Ginger compared
  • EuroVita EV.EXT 77 / Zinaxin

    Standardized ginger extract (5% gingerols + shogaols)

    Standardized active content — what every clinical trial used

    Best forNausea, knee OA pain, dysmenorrhea — any indication where dose consistency matters

    If a label specifies '5% gingerols' or names a clinically tested extract (EV.EXT 77, Zinaxin), the dose on the label is the dose you get. Generic 'ginger root extract' without standardization is closer to powder.

  • Ginger root powder (capsule)

    Variable — ~1–2% gingerols by weight, depending on source

    Best forPregnancy nausea (the Vutyavanich and Smith trials used powder, not extract)

    1 g/day powdered ginger is the dose validated for nausea of pregnancy. Sourcing matters — older or poorly stored powder loses gingerol content over time.

  • Ginger essential oil (capsule)

    Concentrated gingerols and zingiberene; small clinical evidence base

    Best forOften co-formulated with other anti-nausea ingredients

    Less standardized than extract products. Aromatherapy use of essential oil is separate from oral capsule use — do not conflate.

  • Ginger (whole root, tea, fresh)

    Variable — 2–5% gingerol content by fresh weight, lower in dried

    Best forCulinary, mild nausea, general digestive comfort

    Fresh ginger tea is pleasant and mildly effective for queasiness. It is not a therapeutic dose for chemotherapy nausea, knee osteoarthritis, or dysmenorrhea — those endpoints need standardized 1–2 g/day.

  • Crystallized / candied ginger

    Low — sugar coating dilutes active gingerol content

    Best forMild queasiness, palatable form for kids

    Effectively a sugar candy with ginger flavor. Useful for mild nausea, useless as a therapeutic dose for any clinical endpoint.

Side effects and drug interactions

Side effects

  • Heartburn and GI upset

    Common · ≥2 g/day, especially on empty stomach

    The most common dose-limiting side effect. Driven by gastric prokinetic action and direct mucosal irritation at higher doses.

  • Mouth and throat irritation

    Uncommon

    Direct contact effect from raw or concentrated ginger preparations. Capsules avoid this.

  • Increased bleeding risk

    Uncommon

    Ginger inhibits platelet aggregation and modulates thromboxane synthesis. Clinically meaningful when stacked with anticoagulants, antiplatelets, or in the perioperative window.

  • Hypoglycemia

    Uncommon

    Modest glucose-lowering effect can stack with antidiabetic medication. Most relevant in adults already on insulin or sulfonylureas.

  • Gallbladder pain or biliary colic

    Uncommon

    Ginger is a cholagogue — it stimulates bile flow and gallbladder contraction. Can provoke pain in adults with gallstones or biliary obstruction.

Drug interactions

  • Combined-effect risk

    warfarinapixabanrivaroxabandabigatranclopidogrelaspirin (antiplatelet doses)

    Ginger inhibits platelet aggregation and modulates thromboxane B2. Stacks additively with prescription antithrombotics, with case reports of INR elevation on warfarin after starting ginger.

    Discuss with the prescriber before combining. Stop ginger at least 2 weeks before any planned surgery.

  • Combined-effect risk

    insulinmetforminsulfonylureas (glipizide, glyburide)

    Modest glucose-lowering effect adds to prescription antidiabetic action.

    Monitor blood glucose when starting regular ginger supplementation alongside diabetic medication.

  • Additive effect

    calcium channel blockers (nifedipine, amlodipine)

    Ginger may potentiate calcium-channel-blocker effects on platelet function and blood pressure. Mostly preclinical with limited case reports.

    Watch for additive hypotension or bleeding when stacking; discuss with prescriber if symptoms develop.

  • Other

    chemotherapy agents (oncology)

    Despite ginger's antiemetic role in chemotherapy support, oncology guidance is to disclose any supplement use given variable interactions with specific regimens.

    Use ginger for chemotherapy-induced nausea only with oncology team approval — they will check it against your specific regimen.

Other critical caveats
  • Stop ginger at least 2 weeks before any planned surgery. Antiplatelet effects stack with NSAIDs, prescription anticoagulants, and surgical bleeding risk.
  • Active gallstones or biliary obstruction is a contraindication. Ginger stimulates gallbladder contraction and can provoke biliary colic.
  • In pregnancy, low-dose ginger (≤1 g/day) is widely considered safe and is supported by ACOG for nausea of pregnancy. Higher doses lack long-term safety data — discuss with an OB before regular use, especially in the first trimester.
  • If you take warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel, or daily aspirin, do not start ginger without clearing it with your prescriber. INR elevations and bleeding events are documented in the case-report literature.
  • Diabetics on insulin or sulfonylureas — monitor glucose when starting ginger. The modest glycemic effect is additive.
Frequently asked
  • Does ginger actually help with morning sickness?
    Yes — this is one of the most evidence-backed uses of any herb. Borrelli's 2005 systematic review (n=675), the Vutyavanich and Smith RCTs, and ACOG all support ginger 1–1.5 g/day as a non-pharmacological option for nausea of pregnancy. Most data is on short-term use; for regular daily use across a trimester, talk to your OB first.
  • How much ginger for chemotherapy nausea?
    0.5–1 g/day standardized extract added to your prescribed antiemetics, starting 3 days before chemotherapy and continuing through the first 3 days after — that's the Ryan 2012 protocol (n=576). Adjunct, not replacement: keep your 5-HT3 antagonists and dexamethasone. And clear it with your oncologist first.
  • Will ginger help my knee osteoarthritis?
    Modestly. The Bartels 2015 meta-analysis of 5 RCTs (n=593) found a real but modest pain reduction (SMD −0.30) and disability reduction at 500–1,000 mg/day standardized extract. NNT is roughly 9 — useful as an NSAID-sparing adjunct, not a replacement for prescription pain management in moderate-severe disease.
  • Is ginger really better than Dramamine for motion sickness?
    The Mowrey 1982 Lancet trial said yes — but that was 36 people in a single rotating-chair test. Modern reviews position ginger as a reasonable option, not a definitively better one. 940 mg–1 g of powdered ginger taken 30 minutes before travel is the dose to try. If you have a serious motion-sickness problem, scopolamine patches still outperform.
  • Can I take ginger with my blood thinner?
    Discuss with your prescriber first. Ginger inhibits platelet aggregation and modulates thromboxane — case reports include INR spikes on warfarin after starting ginger. Real-world risk is dose-dependent (cooking-level ginger is fine, daily 1–2 g supplement is the concern), but if you are on warfarin, apixaban, rivaroxaban, or daily aspirin, get your prescriber's signoff before adding regular ginger supplementation.
  • Does ginger lower blood sugar?
    Modestly, yes — but the data is weaker than for nausea. Some meta-analyses show fasting glucose drops in type 2 diabetes; effect sizes are smaller than first-line glucose-lowering drugs. Useful as a tail benefit if you are taking ginger for nausea or joint pain anyway. Not a glycemic strategy on its own. If you are on insulin or sulfonylureas, monitor your glucose when adding daily ginger.
  • Tea, capsule, or extract — which form should I take?
    For nausea of pregnancy: 1 g/day powdered ginger in capsules is the trial-validated dose. For chemotherapy, post-op, knee OA, or dysmenorrhea: standardized extract (5% gingerols) at 500–2,000 mg/day matches what the trials used. Ginger tea is pleasant and mildly effective for queasiness but is not a therapeutic dose for any clinical endpoint. Crystallized ginger is mostly sugar.

References

  1. 01NCCIH — Ginger Health Information
  2. 02Examine.com — Ginger
  3. 03ACOG Practice Bulletin — Nausea and Vomiting of Pregnancy

Last reviewed2026-05-07